Greenwich Lifesciences Inc (GLSI)

Mar 10, 2025

Trading (GLSI) With Integrated Risk Controls - Stock Traders Daily

Mar 10, 2025

Mar 05, 2025

Non-Small Cell Lung Cancer Clinical Trial Pipeline | 100+ Companies Pioneering the Future of Treatment - openPR

Mar 05, 2025

Mar 05, 2025

55% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently - Yahoo Finance

Mar 05, 2025

Feb 27, 2025

Learn to Evaluate (GLSI) using the Charts - Stock Traders Daily

Feb 27, 2025

Feb 22, 2025

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Sees Large Increase in Short Interest - MarketBeat

Feb 22, 2025

Feb 21, 2025

Short Interest in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Increases By 5.1% - MarketBeat

Feb 21, 2025

Feb 20, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Verra Mobility Corporation (NASDAQ: VRRM) - PR Newswire

Feb 20, 2025

Feb 18, 2025

Pre-market Movers: TNXP, INBS, SMMT, NDRA... - RTTNews

Feb 18, 2025

Feb 18, 2025

Research Analysts Set Expectations for GLSI FY2024 Earnings - MarketBeat

Feb 18, 2025

Feb 15, 2025

HC Wainwright Reiterates Buy Rating for Greenwich LifeSciences (NASDAQ:GLSI) - MarketBeat

Feb 15, 2025

Feb 15, 2025

What is HC Wainwright’s Estimate for GLSI FY2024 Earnings? - Defense World

Feb 15, 2025

Feb 12, 2025

Greenwich LifeSciences reports progress in FLAMINGO-01 trial - MSN

Feb 12, 2025

Feb 11, 2025

Greenwich LifeSciences (NASDAQ:GLSI) Given “Buy” Rating at HC Wainwright - Defense World

Feb 11, 2025

Feb 11, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Greenwich LifeSciences, Inc. (NASDAQ: GLSI) - PR Newswire

Feb 11, 2025

Feb 11, 2025

Walmart (NYSE:WMT) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World

Feb 11, 2025

Feb 10, 2025

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 - GlobeNewswire

Feb 10, 2025

Feb 10, 2025

Greenwich LifeSciences reports progress in FLAMINGO-01 trial By Investing.com - Investing.com UK

Feb 10, 2025

Feb 10, 2025

Clinical Trial Success: Greenwich's Breast Cancer Immunotherapy Achieves Critical Patient Milestone - StockTitan

Feb 10, 2025

Feb 06, 2025

Greenwich LifeSciences: Long Time To Results, Little Cash, Hard To Recommend (GLSI) - Seeking Alpha

Feb 06, 2025

Feb 06, 2025

(GLSI) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 06, 2025

Jan 30, 2025

EMA approves addition of sites to Greenwich LifeSciences’ breast cancer trial - Yahoo Finance

Jan 30, 2025

Jan 29, 2025

Greenwich LifeSciences Gets EU Drug Regulator Approval to Add Sites to GLSI-100 Late-Stage Trial - Marketscreener.com

Jan 29, 2025

Jan 29, 2025

Greenwich LifeSciences stock gains on approval to add additional sites to Flamingo-01 in Europe - MSN

Jan 29, 2025

Jan 29, 2025

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe - GlobeNewswire

Jan 29, 2025

Jan 29, 2025

Major Breakthrough: Cancer Prevention Trial Goes Europe-Wide as Top Medical Centers Join Forces - StockTitan

Jan 29, 2025

Jan 28, 2025

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland - GlobeNewswire

Jan 28, 2025

Jan 27, 2025

Greenwich LifeSciences Expands Phase III Breast Cancer Trial Across Poland - StockTitan

Jan 27, 2025

Jan 26, 2025

How to Take Advantage of moves in (GLSI) - Stock Traders Daily

Jan 26, 2025

Jan 24, 2025

Greenwich LifeSciences gains after GP2 commercial manufacturing update - MSN

Jan 24, 2025

Jan 24, 2025

Barclays PLC Has $123,000 Stake in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) - Defense World

Jan 24, 2025

Jan 23, 2025

Bullish Greenwich LifeSciences Insiders Loaded Up On US$3.39m Of Stock - Yahoo Finance

Jan 23, 2025

Jan 23, 2025

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01 - GlobeNewswire

Jan 23, 2025

Jan 23, 2025

Harvard, Johns Hopkins Join Greenwich LifeSciences' Phase III Breast Cancer Vaccine Trial - StockTitan

Jan 23, 2025

Jan 22, 2025

Greenwich LifeSciences stock gains on GP2 update (GLSI) - Seeking Alpha

Jan 22, 2025

Jan 22, 2025

Greenwich LifeSciences Provides Update on Commercial Manufacturing - GlobeNewswire

Jan 22, 2025

Jan 22, 2025

Greenwich LifeSciences Achieves Major Manufacturing Milestone for Breast Cancer Immunotherapy GP2 - StockTitan

Jan 22, 2025

Jan 17, 2025

Glancy Prongay & Murray LLP Announces Investigation of Greenwich LifeSciences, Inc. (GLSI) - Marketscreener.com

Jan 17, 2025

Jan 15, 2025

Long Term Trading Analysis for (GLSI) - Stock Traders Daily

Jan 15, 2025

Jan 14, 2025

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01 - GlobeNewswire

Jan 14, 2025

Jan 14, 2025

Greenwich LifeSciences expands trial sites in Germany - Investing.com India

Jan 14, 2025

Jan 14, 2025

Greenwich Lifesciences Announces Partnership with GBG in Germany for Flamingo-01 - Marketscreener.com

Jan 14, 2025

Jan 14, 2025

Cancer Vaccines Market Global Forecast to 2032: National - GlobeNewswire

Jan 14, 2025

Jan 13, 2025

Greenwich LifeSciences CEO acquires $31,275 in common stock By Investing.com - Investing.com Australia

Jan 13, 2025

Jan 13, 2025

Greenwich LifeSciences CEO acquires $31,275 in common stock - Investing.com India

Jan 13, 2025

Jan 13, 2025

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Buys 2,500 Shares - MarketBeat

Jan 13, 2025

Jan 13, 2025

Insider Buying: Snehal Patel Acquires Additional Shares of Green - GuruFocus.com

Jan 13, 2025